Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Chitosan Market by Source (Shrimp, Squid, Crab, Krill, Others) , by Application (Water treatment, Biomedical and Pharmaceutical, Cosmetics, Food and Beverage, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A01409

Pages: 300

Charts: 59

Tables: 176

Chitosan Market Research, 2033

The global chitosan market was valued at $7.8 billion in 2023, and is projected to reach $42.8 billion by 2033, growing at a CAGR of 18.7% from 2024 to 2033.

Market Introduction and Definition

Chitosan is a natural polysaccharide derived from chitin, which is found in the exoskeletons of crustaceans such as shrimp, crabs, and lobsters. It is produced through a process of deacetylation, where chitin is treated with an alkaline substance to remove acetyl groups, converting it into chitosan. This biopolymer is known for its biocompatibility, biodegradability, and non-toxicity, making it highly valuable in various applications.

Chitosan possesses excellent film-forming and gelling properties, which are beneficial in medical and pharmaceutical fields for wound dressings, drug delivery systems, and tissue engineering. It also has antimicrobial properties, enhancing its use in food preservation and packaging. In agriculture, chitosan is used as a natural pesticide and plant growth enhancer. In addition, its ability to chelate metals makes it useful in water treatment processes for removing heavy metals and other contaminants. Chitosan's versatility and eco-friendly nature drive its demand across multiple industries, despite production and regulatory challenges.

Key Takeaways

  • The chitosan market study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major chitosan industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Source
    • Shrimp
    • Squid
    • Crab
    • Krill
    • Others
  • By Application
    • Water treatment
    • Biomedical and Pharmaceutical
    • Cosmetics
    • Food and Beverage
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • PRIMEX EHF
  • Kitozyme S.A.
  • Golden-Shell Pharmaceutical Co. Ltd.
  • Heppe Medical Chitosan GmbH
  • G.T.C. Bio Corporation
  • Qingdao Yunzhou Biochemistry Co. Ltd.
  • ADVANCED BIOPOLYMERS AS
  • Panvo Organics Pvt Ltd.
  • Novamatrix
  • Agratech International, Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: CHITOSAN MARKET, BY SOURCE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Source

    • 4.2. Shrimp

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Squid

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Crab

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Krill

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Others

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: CHITOSAN MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Water Treatment

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Biomedical And Pharmaceutical

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cosmetics

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Food And Beverage

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Others

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: CHITOSAN MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Source

      • 6.2.3. Market Size and Forecast, By Application

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Chitosan Market

        • 6.2.5.1. Market Size and Forecast, By Source
        • 6.2.5.2. Market Size and Forecast, By Application

      • 6.2.6. Canada Chitosan Market

        • 6.2.6.1. Market Size and Forecast, By Source
        • 6.2.6.2. Market Size and Forecast, By Application

      • 6.2.7. Mexico Chitosan Market

        • 6.2.7.1. Market Size and Forecast, By Source
        • 6.2.7.2. Market Size and Forecast, By Application

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Source

      • 6.3.3. Market Size and Forecast, By Application

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Chitosan Market

        • 6.3.5.1. Market Size and Forecast, By Source
        • 6.3.5.2. Market Size and Forecast, By Application

      • 6.3.6. Germany Chitosan Market

        • 6.3.6.1. Market Size and Forecast, By Source
        • 6.3.6.2. Market Size and Forecast, By Application

      • 6.3.7. Italy Chitosan Market

        • 6.3.7.1. Market Size and Forecast, By Source
        • 6.3.7.2. Market Size and Forecast, By Application

      • 6.3.8. Spain Chitosan Market

        • 6.3.8.1. Market Size and Forecast, By Source
        • 6.3.8.2. Market Size and Forecast, By Application

      • 6.3.9. UK Chitosan Market

        • 6.3.9.1. Market Size and Forecast, By Source
        • 6.3.9.2. Market Size and Forecast, By Application

      • 6.3.10. Russia Chitosan Market

        • 6.3.10.1. Market Size and Forecast, By Source
        • 6.3.10.2. Market Size and Forecast, By Application

      • 6.3.11. Rest Of Europe Chitosan Market

        • 6.3.11.1. Market Size and Forecast, By Source
        • 6.3.11.2. Market Size and Forecast, By Application

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Source

      • 6.4.3. Market Size and Forecast, By Application

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Chitosan Market

        • 6.4.5.1. Market Size and Forecast, By Source
        • 6.4.5.2. Market Size and Forecast, By Application

      • 6.4.6. Japan Chitosan Market

        • 6.4.6.1. Market Size and Forecast, By Source
        • 6.4.6.2. Market Size and Forecast, By Application

      • 6.4.7. India Chitosan Market

        • 6.4.7.1. Market Size and Forecast, By Source
        • 6.4.7.2. Market Size and Forecast, By Application

      • 6.4.8. South Korea Chitosan Market

        • 6.4.8.1. Market Size and Forecast, By Source
        • 6.4.8.2. Market Size and Forecast, By Application

      • 6.4.9. Australia Chitosan Market

        • 6.4.9.1. Market Size and Forecast, By Source
        • 6.4.9.2. Market Size and Forecast, By Application

      • 6.4.10. Thailand Chitosan Market

        • 6.4.10.1. Market Size and Forecast, By Source
        • 6.4.10.2. Market Size and Forecast, By Application

      • 6.4.11. Malaysia Chitosan Market

        • 6.4.11.1. Market Size and Forecast, By Source
        • 6.4.11.2. Market Size and Forecast, By Application

      • 6.4.12. Indonesia Chitosan Market

        • 6.4.12.1. Market Size and Forecast, By Source
        • 6.4.12.2. Market Size and Forecast, By Application

      • 6.4.13. Rest of Asia Pacific Chitosan Market

        • 6.4.13.1. Market Size and Forecast, By Source
        • 6.4.13.2. Market Size and Forecast, By Application

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Source

      • 6.5.3. Market Size and Forecast, By Application

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Chitosan Market

        • 6.5.5.1. Market Size and Forecast, By Source
        • 6.5.5.2. Market Size and Forecast, By Application

      • 6.5.6. South Africa Chitosan Market

        • 6.5.6.1. Market Size and Forecast, By Source
        • 6.5.6.2. Market Size and Forecast, By Application

      • 6.5.7. Saudi Arabia Chitosan Market

        • 6.5.7.1. Market Size and Forecast, By Source
        • 6.5.7.2. Market Size and Forecast, By Application

      • 6.5.8. UAE Chitosan Market

        • 6.5.8.1. Market Size and Forecast, By Source
        • 6.5.8.2. Market Size and Forecast, By Application

      • 6.5.9. Argentina Chitosan Market

        • 6.5.9.1. Market Size and Forecast, By Source
        • 6.5.9.2. Market Size and Forecast, By Application

      • 6.5.10. Rest of LAMEA Chitosan Market

        • 6.5.10.1. Market Size and Forecast, By Source
        • 6.5.10.2. Market Size and Forecast, By Application

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. PRIMEX EHF

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. ADVANCED BIOPOLYMERS AS

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Panvo Organics Pvt Ltd.

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Heppe Medical Chitosan GmbH

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. G.T.C. Bio Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Kitozyme S.A.

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Novamatrix

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Agratech International, Inc.

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Golden-Shell Pharmaceutical Co. Ltd.

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Qingdao Yunzhou Biochemistry Co. Ltd.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CHITOSAN MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL CHITOSAN MARKET FOR SHRIMP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL CHITOSAN MARKET FOR SQUID, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL CHITOSAN MARKET FOR CRAB, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL CHITOSAN MARKET FOR KRILL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL CHITOSAN MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL CHITOSAN MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL CHITOSAN MARKET FOR WATER TREATMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL CHITOSAN MARKET FOR BIOMEDICAL AND PHARMACEUTICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL CHITOSAN MARKET FOR COSMETICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL CHITOSAN MARKET FOR FOOD AND BEVERAGE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL CHITOSAN MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL CHITOSAN MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA CHITOSAN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. U.S. CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 18. U.S. CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. CANADA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 20. CANADA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. MEXICO CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. EUROPE CHITOSAN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. FRANCE CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 27. FRANCE CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. GERMANY CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 29. GERMANY CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. ITALY CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 31. ITALY CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. SPAIN CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 33. SPAIN CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. UK CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 35. UK CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. RUSSIA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 37. RUSSIA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. REST OF EUROPE CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 39. REST OF EUROPE CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. ASIA-PACIFIC CHITOSAN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. CHINA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 44. CHINA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. JAPAN CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 46. JAPAN CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. INDIA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 48. INDIA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. SOUTH KOREA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 50. SOUTH KOREA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. AUSTRALIA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 52. AUSTRALIA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. THAILAND CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 54. THAILAND CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. MALAYSIA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 56. MALAYSIA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. INDONESIA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 58. INDONESIA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. REST OF ASIA PACIFIC CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. LAMEA CHITOSAN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. BRAZIL CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 65. BRAZIL CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH AFRICA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH AFRICA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. SAUDI ARABIA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 69. SAUDI ARABIA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. UAE CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 71. UAE CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. ARGENTINA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 73. ARGENTINA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. REST OF LAMEA CHITOSAN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 75. REST OF LAMEA CHITOSAN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. PRIMEX EHF: KEY EXECUTIVES
  • TABLE 77. PRIMEX EHF: COMPANY SNAPSHOT
  • TABLE 78. PRIMEX EHF: OPERATING SEGMENTS
  • TABLE 79. PRIMEX EHF: PRODUCT PORTFOLIO
  • TABLE 80. PRIMEX EHF: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. ADVANCED BIOPOLYMERS AS: KEY EXECUTIVES
  • TABLE 82. ADVANCED BIOPOLYMERS AS: COMPANY SNAPSHOT
  • TABLE 83. ADVANCED BIOPOLYMERS AS: OPERATING SEGMENTS
  • TABLE 84. ADVANCED BIOPOLYMERS AS: PRODUCT PORTFOLIO
  • TABLE 85. ADVANCED BIOPOLYMERS AS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. PANVO ORGANICS PVT LTD.: KEY EXECUTIVES
  • TABLE 87. PANVO ORGANICS PVT LTD.: COMPANY SNAPSHOT
  • TABLE 88. PANVO ORGANICS PVT LTD.: OPERATING SEGMENTS
  • TABLE 89. PANVO ORGANICS PVT LTD.: PRODUCT PORTFOLIO
  • TABLE 90. PANVO ORGANICS PVT LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. HEPPE MEDICAL CHITOSAN GMBH: KEY EXECUTIVES
  • TABLE 92. HEPPE MEDICAL CHITOSAN GMBH: COMPANY SNAPSHOT
  • TABLE 93. HEPPE MEDICAL CHITOSAN GMBH: OPERATING SEGMENTS
  • TABLE 94. HEPPE MEDICAL CHITOSAN GMBH: PRODUCT PORTFOLIO
  • TABLE 95. HEPPE MEDICAL CHITOSAN GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. G.T.C. BIO CORPORATION: KEY EXECUTIVES
  • TABLE 97. G.T.C. BIO CORPORATION: COMPANY SNAPSHOT
  • TABLE 98. G.T.C. BIO CORPORATION: OPERATING SEGMENTS
  • TABLE 99. G.T.C. BIO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 100. G.T.C. BIO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. KITOZYME S.A.: KEY EXECUTIVES
  • TABLE 102. KITOZYME S.A.: COMPANY SNAPSHOT
  • TABLE 103. KITOZYME S.A.: OPERATING SEGMENTS
  • TABLE 104. KITOZYME S.A.: PRODUCT PORTFOLIO
  • TABLE 105. KITOZYME S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. NOVAMATRIX: KEY EXECUTIVES
  • TABLE 107. NOVAMATRIX: COMPANY SNAPSHOT
  • TABLE 108. NOVAMATRIX: OPERATING SEGMENTS
  • TABLE 109. NOVAMATRIX: PRODUCT PORTFOLIO
  • TABLE 110. NOVAMATRIX: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. AGRATECH INTERNATIONAL, INC.: KEY EXECUTIVES
  • TABLE 112. AGRATECH INTERNATIONAL, INC.: COMPANY SNAPSHOT
  • TABLE 113. AGRATECH INTERNATIONAL, INC.: OPERATING SEGMENTS
  • TABLE 114. AGRATECH INTERNATIONAL, INC.: PRODUCT PORTFOLIO
  • TABLE 115. AGRATECH INTERNATIONAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: KEY EXECUTIVES
  • TABLE 117. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: COMPANY SNAPSHOT
  • TABLE 118. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: OPERATING SEGMENTS
  • TABLE 119. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 120. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: KEY EXECUTIVES
  • TABLE 122. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: COMPANY SNAPSHOT
  • TABLE 123. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: OPERATING SEGMENTS
  • TABLE 124. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 125. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CHITOSAN MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CHITOSAN MARKET
  • FIGURE 3. SEGMENTATION CHITOSAN MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CHITOSAN MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCHITOSAN MARKET
  • FIGURE 11. CHITOSAN MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 12. CHITOSAN MARKET FOR SHRIMP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. CHITOSAN MARKET FOR SQUID, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. CHITOSAN MARKET FOR CRAB, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. CHITOSAN MARKET FOR KRILL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. CHITOSAN MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. CHITOSAN MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 18. CHITOSAN MARKET FOR WATER TREATMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. CHITOSAN MARKET FOR BIOMEDICAL AND PHARMACEUTICAL, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. CHITOSAN MARKET FOR COSMETICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. CHITOSAN MARKET FOR FOOD AND BEVERAGE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. CHITOSAN MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: CHITOSAN MARKET
  • FIGURE 29. TOP PLAYER POSITIONING, 2024
  • FIGURE 30. PRIMEX EHF: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. PRIMEX EHF: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. PRIMEX EHF: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. ADVANCED BIOPOLYMERS AS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ADVANCED BIOPOLYMERS AS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ADVANCED BIOPOLYMERS AS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. PANVO ORGANICS PVT LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. PANVO ORGANICS PVT LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. PANVO ORGANICS PVT LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. HEPPE MEDICAL CHITOSAN GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. HEPPE MEDICAL CHITOSAN GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. HEPPE MEDICAL CHITOSAN GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. G.T.C. BIO CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. G.T.C. BIO CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. G.T.C. BIO CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. KITOZYME S.A.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. KITOZYME S.A.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. KITOZYME S.A.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. NOVAMATRIX: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. NOVAMATRIX: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. NOVAMATRIX: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. AGRATECH INTERNATIONAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. AGRATECH INTERNATIONAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. AGRATECH INTERNATIONAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. GOLDEN-SHELL PHARMACEUTICAL CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. QINGDAO YUNZHOU BIOCHEMISTRY CO. LTD.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Chitosan Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved